Page last updated: 2024-09-05

varenicline and Dry Eye

varenicline has been researched along with Dry Eye in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's14 (100.00)2.80

Authors

AuthorsStudies
Chiu, KH; Henry, E; Nau, J; Paauw, J; Striffler, K; Vollmer, P; Wirta, D1
Chiu, KH; Henry, E; Hernandez-Quintela, E; Nau, JA; Quiroz-Mercado, H1
Gibson, AA; Hendrix, LH; Macsai, M; Sun, L; Tam, I; Visco, DM1
Dougherty, TS; Ladd, L; Zitko, KL1
Jerkins, G; Nau, J; Pattar, GR; Striffler, K; Torkildsen, GL1
Gibson, AA; Hendrix, LH; Macsai, M; Sun, L; Tam, I; White, DE1
Ackermann, M; Bendert, E; Boehmer, B; Hollander, DA; Nau, J; Torkildsen, GL; Wirta, D; Zeng, L1
Frampton, JE1
Blemker, G; Gibson, A; Hemphill, M; Hendrix, LH; Karpecki, PM; Macsai, M; O'Dell, LE; Raizman, MB; Sheppard, JD; Whitley, WO1
Gibson, A; Hemphill, M; Hendrix, LH; Kabat, AG; Katz, J; Maiti, S; Periman, LM; Sarnicola, E; Shah, P1
Gibson, AA; Hauswirth, SG; Hemphill, M; Hendrix, LH; Kabat, AG; Somaiya, K1
Hayslett, RL; Marshall, LL1
Aldahlawi, A; Alghamdi, S; Alkhathlan, M; Alnabihi, A; Alzahrani, Z; Bashrahil, B; Taher, N1

Reviews

4 review(s) available for varenicline and Dry Eye

ArticleYear
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease.
    Journal of managed care & specialty pharmacy, 2022, Volume: 28, Issue:8

    Topics: Cyclosporine; Dry Eye Syndromes; Emulsions; Humans; Immunosuppressive Agents; Nasal Sprays; Ophthalmic Solutions; Tears; Treatment Outcome; Varenicline

2022
Intranasal Varenicline: Review of a Novel Formulation for the Treatment of Dry Eye Disease.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:6

    Topics: Dry Eye Syndromes; Humans; Tears; Varenicline

2023
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease.
    Drugs, 2022, Volume: 82, Issue:14

    Topics: Administration, Ophthalmic; Dry Eye Syndromes; Humans; Nasal Sprays; Tears; Varenicline

2022
The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis.
    BMC ophthalmology, 2023, Jul-14, Volume: 23, Issue:1

    Topics: Dry Eye Syndromes; Humans; Nasal Sprays; Varenicline

2023

Trials

8 trial(s) available for varenicline and Dry Eye

ArticleYear
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial.
    Ophthalmology, 2022, Volume: 129, Issue:4

    Topics: Adult; Double-Blind Method; Dry Eye Syndromes; Humans; Lubricant Eye Drops; Nasal Sprays; Ophthalmic Solutions; Tears; Treatment Outcome; Varenicline

2022
A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study.
    The ocular surface, 2022, Volume: 24

    Topics: Dry Eye Syndromes; Humans; Nasal Sprays; Tears; Treatment Outcome; Varenicline

2022
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.
    Clinical therapeutics, 2022, Volume: 44, Issue:9

    Topics: Adult; Double-Blind Method; Dry Eye Syndromes; Fluorescein; Humans; Nasal Sprays; Ophthalmic Solutions; Receptors, Nicotinic; Varenicline

2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease.
    Journal of managed care & specialty pharmacy, 2023, Volume: 29, Issue:1

    Topics: Data Collection; Dry Eye Syndromes; Humans; Nasal Sprays; Ophthalmic Solutions; Treatment Outcome; Varenicline

2023
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease.
    Cornea, 2022, Oct-01, Volume: 41, Issue:10

    Topics: Dry Eye Syndromes; Humans; Lubricant Eye Drops; Nasal Sprays; Receptors, Nicotinic; Treatment Outcome; Varenicline

2022
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
    Optometry and vision science : official publication of the American Academy of Optometry, 2023, 02-01, Volume: 100, Issue:2

    Topics: Adult; Dry Eye Syndromes; Humans; Nasal Sprays; Ophthalmic Solutions; Patient Acuity; Tears; Treatment Outcome; Varenicline

2023
Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease.
    Clinical therapeutics, 2022, Volume: 44, Issue:11

    Topics: Dry Eye Syndromes; Humans; Nasal Sprays; Varenicline

2022
Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease.
    Journal of comparative effectiveness research, 2023, Volume: 12, Issue:6

    Topics: Cyclosporine; Dry Eye Syndromes; Humans; Nasal Sprays; Ophthalmic Solutions; Treatment Outcome; Varenicline

2023

Other Studies

2 other study(ies) available for varenicline and Dry Eye

ArticleYear
Varenicline nasal spray (Tyrvaya) for dry eye disease.
    The Medical letter on drugs and therapeutics, 2021, 12-13, Volume: 63, Issue:1639

    Topics: Administration, Intranasal; Dry Eye Syndromes; Humans; Nasal Sprays; Varenicline

2021
Dry Eye Disease: Focus on Prescription Therapy.
    The Senior care pharmacist, 2023, Jun-01, Volume: 38, Issue:6

    Topics: Cyclosporins; Dry Eye Syndromes; Humans; Lubricants; Nasal Sprays; Ophthalmic Solutions; Prescriptions; United States; Varenicline

2023
chemdatabank.com